Pharmaceutical therapeutic use of glutathione derivative

Details Pharmaceutical therapeutic use of glutathione derivative Pharmaceutical therapeutic use of glutathione derivative

1997-08-20

2000-02-29

Davenport, Avis M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530331, 530332, A61K 3800, C07K 500, C07K 700

Patent

active

060309504

ABSTRACT:
Methods of adjusting or maintaining the intracellular levels of glutathione of a subject are provided. The subject is treated by administering an effective amount of an acetyl derivative of glutathione.

REFERENCES:
patent: 2760956 (1956-08-01), Brick
patent: 3950387 (1976-04-01), Joullie et al.
patent: 3984569 (1976-10-01), Kalopissis et al.
patent: 4618669 (1986-10-01), Dereu et al.
patent: 4900719 (1990-02-01), Means et al.
patent: 5232913 (1993-08-01), Ohmori et al.
patent: 5238683 (1993-08-01), Crystal
Berkow et al, The Merck Manual, Table 262-1 (1982).
Perchellet et al, Cancer Res. 47:477-485 (1987).
Novi et al, Science 212:541-542 (May 1981).
Anderson et al, Arch. Biochem. Biophys. 239:538-548 (1985).
Vince et al, Biochem. Biophys. Res. Comm. 35:593-598 (1969).

Affiliated with

Also associated with

Rating

Pharmaceutical therapeutic use of glutathione derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical therapeutic use of glutathione derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical therapeutic use of glutathione derivative will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-683060